publication venue for
- Phase 1b Study of Tovorafenib, Plozalizumab or Vedolizumab Plus Standard-of-Care Immune Checkpoint Inhibitors in Patients with Advanced Melanoma.. 16. 2025
- Downregulation of LOX promotes castration-resistant prostate cancer progression via IGFBP3.. 12. 2021
- Increased expression of CELSR3 indicates a poor prognostic factor for Prostate Cancer.. 12. 2021
- Ethanol Enhances Estrogen Mediated Angiogenesis in Breast Cancer.. 9. 2018
- Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation.. 8. 2017
- Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer.. 5. 2014
- Is high dose therapy superior to conventional dose therapy as initial treatment for relapsed germ cell tumors? The TIGER Trial.. 2. 2011
- Hepatocellular Carcinoma and Diffusion-Weighted MRI: Detection and Evaluation of Treatment Response. 2016